Distinctive roles of Rac1 and Rab29 in LRRK2 mediated membrane trafficking and neurite outgrowth

Area of Science:

• Cell Biology
• Neuroscience
• Biochemistry

Background:

• Mutations in leucine-rich repeat kinase 2 (LRRK2) are linked to Parkinson's disease (PD).
• The small GTPases Rac1 and Rab29 are proposed downstream effectors of LRRK2 signaling, but their precise roles are not fully understood.

Purpose of the Study:

• To investigate the interaction between LRRK2 and the GTPases Rac1 and Rab29.
• To elucidate the distinct mechanisms by which Rac1 and Rab29 function in LRRK2-mediated pathogenesis.

Main Methods:

• Biochemical assays to confirm protein interactions.
• Cell biology techniques to analyze subcellular processes and protein trafficking.
• Utilized differentiated SH-SY5Y cells to model neurite shortening.

Main Results:

• Rac1 and Rab29 specifically bind to LRRK2, with Rab29 showing higher affinity.
• Mutant Rab29, but not Rac1, disrupts endosome-to-TGN retrograde trafficking and CI-M6PR stability.
• Wild-type Rab29, but not Rac1, rescues LRRK2^G2019S-induced trafficking defects.
• Both Rac1 and Rab29 can ameliorate LRRK2^G2019S-induced neurite shortening in neuronal cells.

Conclusions:

• Rac1 and Rab29 act as distinct downstream effectors in LRRK2 signaling pathways.
• These GTPases play separate roles in LRRK2-associated cellular dysfunction relevant to Parkinson's disease.